drugset / Trial / NCT02209506
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of single and multiple oral dosing of MLN3126 in ascending doses in healthy non-Japanese and Japanese participants.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-09
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped: “Long-term animal toxicology findings (see detailed description).”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MLN3126 | Unknown | 100 mg | Oral |
| Subject | MLN3126 | Unknown | 300 mg | Oral |
| Subject | MLN3126 | Unknown | 800 mg | Oral |
Indications
No indication recorded.